Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for their anti-
inflammatory, antipyretic, and analgesic properties. However, their use is often associated …

Objectives To assess the association between routinely prescribed non-steroidal anti-
inflammatory drugs (NSAIDs) and deaths from COVID-19 using OpenSAFELY, a secure …

Since the outbreak of the COVID-19 pandemic in December 2019 and its rapid spread
worldwide, the scientific community has been under pressure to react and make progress in …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Objective To investigate whether symptomatic treatment with non-steroidal anti-inflammatory
drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinary …

Non-steroidal anti-inflammatory drugs (NSAIDs) have an optional prescription status that
has resulted in frequent use, in particular for the symptomatic treatment of fever and non …

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate symptoms
during community-acquired pneumonia (CAP), while neither clinical data nor guidelines …

Background Although uncomplicated urinary tract infections (UTIs) are often self-limiting,
most patients will be prescribed antibiotic treatment. We assessed whether treatment with …

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in infants, children, and
adolescents worldwide; however, despite sufficient evidence of the beneficial effects of …